InspireMD, Inc. (NSPR) is a publicly traded Healthcare sector company. As of May 21, 2026, NSPR trades at $1.00 with a market cap of $49.18M and a P/E ratio of -1.33. NSPR moved +1.00% today. Year to date, NSPR is -48.19%; over the trailing twelve months it is -54.34%. Its 52-week range spans $0.97 to $3.80. Analyst consensus is strong buy with an average price target of $3.67. Rallies surfaces NSPR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading NSPR stock inside the company?
Recent NSPR insider activity includes Slosman Marvin bought 21.00K, Stuka Paul bought 10.00K, Stuka Paul bought 10.00K, Stuka Paul bought 65.63K, and Stuka Paul bought 65.63K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
NSPR Key Metrics
Key financial metrics for NSPR
Metric
Value
Price
$1.00
Market Cap
$49.18M
P/E Ratio
-1.33
EPS
$-0.76
Dividend Yield
0.00%
52-Week High
$3.80
52-Week Low
$0.97
Volume
0
Avg Volume
0
Revenue (TTM)
$8.98M
Net Income
$-48.79M
Gross Margin
29.50%
Recent NSPR Insider Trades
Slosman Marvin bought 21.00K (~$25.20K) on May 12, 2026.
Stuka Paul bought 10.00K (~$11.90K) on May 11, 2026.
Stuka Paul bought 10.00K (~$11.90K) on May 11, 2026.
Stuka Paul bought 65.63K (~$76.13K) on May 8, 2026.
Stuka Paul bought 65.63K (~$76.13K) on May 8, 2026.
Recent NSPR insider activity includes Slosman Marvin bought 21.00K, Stuka Paul bought 10.00K, Stuka Paul bought 10.00K, Stuka Paul bought 65.63K, and Stuka Paul bought 65.63K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for NSPR?
Yes. Rallies tracks NSPR insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is NSPR research on Rallies investment advice?
No. Rallies provides research, data, and educational context for NSPR. It does not provide personalized investment advice.
